When Earbuds Become Hearing Aids: Eight OEM/ODM Lessons for Product Teams
Consumer audio and hearing care are no longer separate product worlds. Recent industry coverage reported that compatible Samsung Galaxy Buds are expected to add a self-fitting over-the-counter hearing-aid function for eligible U.S. adults. Apple previously received FDA authorization for hearing-aid software used with compatible AirPods Pro.
For hearing-aid brands, distributors, and OEM/ODM teams, the important story is not that every earbud is becoming a hearing aid. It is that medical-device functionality can now be created by a tightly controlled combination of consumer hardware, software, hearing assessment, fitting logic, labelling, and support.
This convergence creates opportunity, but it also exposes weak product planning. Adding amplification, Bluetooth, or an app does not by itself create a compliant hearing aid. The whole system must support the intended use and the claims made for it.
The category boundary is moving
The U.S. Food and Drug Administration distinguishes hearing aids from personal sound amplification products by intended use. Hearing aids are intended to compensate for impaired hearing. PSAPs are intended for people with normal hearing who want to amplify sounds in particular environments.
The FDA also defines a self-fitting air-conduction hearing aid as a device that incorporates technology, including software, allowing users to program the device to meet their hearing needs without professional assistance. That definition makes the product more than an ear-worn speaker. It connects the acoustic hardware, user interface, fitting strategy, warnings, performance controls, and evidence.
Product teams should therefore treat “hearable,” “OTC hearing aid,” “self-fitting hearing aid,” and “PSAP” as different commercial and regulatory concepts—not interchangeable marketing phrases.
Eight interfaces product teams must manage
1. Intended use defines the regulatory path
The first design input is not the chipset or industrial form. It is the intended user, hearing need, use environment, and market claim. In the United States, OTC hearing aids are for adults age 18 or older with perceived mild-to-moderate hearing impairment. They are not a universal option for children, complex conditions, or every degree of hearing loss.
A product intended to compensate for hearing impairment cannot be repositioned as a general listening enhancer simply by changing a few words on a web page. Conversely, a consumer earbud does not become a regulated hearing aid because it offers transparency mode or adjustable amplification.
2. Clearance applies to a defined system
Software-based hearing functions depend on specified hardware, operating systems, phones, firmware, apps, and setup workflows. Regulatory status applies to the device described in the relevant authorization or clearance—not automatically to every product in a brand family.
OEM/ODM teams should maintain a controlled compatibility matrix. Model numbers, firmware versions, mobile operating systems, wireless requirements, geographic availability, and excluded combinations should be visible to regulatory, engineering, customer service, and commercial teams.
3. Self-fitting is a controlled product function
Self-fitting is not the same as offering a volume slider. A self-fitting strategy uses user input to derive and customize settings for individual hearing needs. That process raises questions about test conditions, calibration, ambient-noise detection, ear-tip fit, error handling, repeatability, usability, and what happens when results fall outside the intended range.
Brands should decide which steps occur on the hearing device, phone, cloud, or support platform. Each dependency adds verification, privacy, cybersecurity, and lifecycle responsibilities.
4. Hardware and software changes must stay synchronized
An acoustic change can affect software performance, and a software update can change the behavior of unchanged hardware. Microphone placement, receiver response, venting, ear tips, battery capacity, latency, wireless stability, and mechanical fit all influence the user experience.
Change control should evaluate the complete system. A substitute microphone, revised charging case, new dome, operating-system update, or algorithm adjustment should not move independently when it could affect verified performance, labelling, compatibility, or risk controls.
5. Evidence must match the claim and population
Product teams need an evidence map linking each meaningful claim to appropriate verification, validation, usability, acoustic, or clinical information. A study on one hardware generation, fitting method, or population may not support a broader claim about another.
Manufacturer announcements and media reports can identify market direction, but they are not substitutes for primary regulatory records, study reports, and model-specific technical documentation. Comparisons such as “medical grade,” “professional accuracy,” or “equivalent to” deserve especially careful review.
6. Everyday usability becomes a safety issue
Consumer earbuds may feel familiar, but hearing-aid use introduces different expectations. Users need to understand insertion, left-right identification, charging, cleaning, maximum output, listening modes, warning signs, and when to stop self-management and seek care.
Battery duration should be evaluated against the intended wearing pattern, not only music playback. Controls must prevent accidental changes. Alerts need to be perceivable. Instructions should work for older adults with varied dexterity, vision, digital confidence, and smartphone access.
7. Support must span devices, phones, apps, and accounts
When a traditional hearing aid fails, troubleshooting is already multifactorial. A connected software-led system can also involve phone compatibility, Bluetooth permissions, app versions, account access, cloud services, firmware, and data synchronization.
Support teams need a decision tree that separates acoustic fit, hardware fault, mobile configuration, software defect, user misunderstanding, and medical red flags. Ownership between the hearing-device brand, phone maker, app provider, retailer, and local service partner must be explicit.
8. Post-market learning needs governance
Connected products can generate useful signals about setup completion, mode selection, errors, returns, and support requests. However, telemetry is not automatically clinical evidence. Consent, data minimization, security, retention, access, cross-border transfer, and interpretation require governance.
Complaint handling and adverse-event escalation must not disappear inside general consumer-electronics support. Product teams should define how recurring issues lead to investigation, corrective action, software updates, user notification, and regulatory reporting where required.
What dedicated hearing-aid brands can learn
Consumer-electronics companies bring strengths in onboarding, mobile integration, familiar form factors, retail reach, and rapid software iteration. Dedicated hearing-aid teams bring acoustic specialization, fitting knowledge, hearing-care workflows, long-wear design, and experience supporting varied hearing needs.
The strategic opportunity is not to imitate earbuds cosmetically. It is to combine accessible setup and connected experiences with disciplined acoustic design, responsible claims, reliable all-day use, replaceable consumables, traceability, and clear care pathways.
Questions for an OEM/ODM design review
- What is the exact intended use, user group, market, and regulatory classification?
- Which hardware, firmware, app, phone, and operating-system combinations form the product?
- How is self-fitting verified under realistic user and environmental conditions?
- Which claims are supported by which model-specific evidence?
- How are acoustic, mechanical, software, and accessory changes controlled together?
- What happens when a hearing result, symptom, or user need falls outside the OTC pathway?
- Can older users complete setup, daily operation, and recovery from errors safely?
- Who owns support, complaints, security updates, and post-market escalation?
Build the evidence chain before the headline
Consumer earbuds entering regulated hearing care will expand awareness and competition. They may also encourage more brands to describe ordinary audio features with medical language. The durable advantage will belong to teams that can show how the intended use, hardware, software, fitting method, validation, labelling, and support system connect.
Tomore works with B2B partners evaluating hearing-aid product and customisation programmes. Share your target market, intended user, product format, connectivity requirements, claim strategy, documentation needs, and expected order volume. Our team can discuss manufacturing scope and product options while keeping market authorization and final claims subject to device-specific regulatory review.